MD Anderson and SNIPR BIOME Collaborate to Advance Next-Generation CRISPR Microbiome Therapeutics
September 14, 2021
September 14, 2021
HOUSTON, Texas, Sept. 14 (TNSJou) -- The University of Texas's MD Anderson Cancer Center issued the following news release on Sept. 13, 2021:
* * *
Research focused on improving immunotherapy-related side effects for patients with cancer
* * *
The University of Texas MD Anderson Cancer Center and SNIPR BIOME today announced a strategic collaboration to advance new CRISPR-based microbiome therapeutics to reduce immune-related adverse events . . .
* * *
Research focused on improving immunotherapy-related side effects for patients with cancer
* * *
The University of Texas MD Anderson Cancer Center and SNIPR BIOME today announced a strategic collaboration to advance new CRISPR-based microbiome therapeutics to reduce immune-related adverse events . . .